Cargando…

Combined effect of D-dimer, hs-CRP, and Lp(a) on 5-year clinical outcomes after percutaneous coronary intervention: A large real-world study in China

To reduce cardiovascular risk in patients with established coronary heart disease, the present study investigated the combined effect of D-dimer, high-sensitivity C-reactive protein (hs-CRP), and lipoprotein(a) [Lp(a)] on long-term cardiovascular outcomes from the perspectives of thrombosis, inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiawen, Zhu, Pei, Tang, Xiaofang, Jiang, Lin, Li, Yulong, Yan, Kailun, Yang, Weixian, Qiao, Shubin, Yang, Yuejin, Gao, Runlin, Xu, Bo, Yuan, Jinqing, Zhao, Xueyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362257/ https://www.ncbi.nlm.nih.gov/pubmed/37485360 http://dx.doi.org/10.1016/j.isci.2023.107030

Ejemplares similares

Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

A novel inflammatory biomarker, high-sensitivity C-reactive protein-to-albumin ratio, is associated with 5-year outcomes in patients with type 2 diabetes who undergo percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World
por: Yan, Kailun, et al.
Publicado: (2023)

D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention
por: Zhao, Xueyan, et al.
Publicado: (2020)

Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention
por: Li, Yulong, et al.
Publicado: (2022)

Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China
por: Li, Jiawen, et al.
Publicado: (2021)

Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention
por: Zhao, Xueyan, et al.
Publicado: (2019)

Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry
por: Tang, Xiaofang, et al.
Publicado: (2021)

The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA
por: Cheng, Rui, et al.
Publicado: (2023)

Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Tianyu, et al.
Publicado: (2021)

Novel Platelet Function Analyzer 200 Predicts Blood Transfusion After Elective Cardiac Surgery in Patients Suspended on Dual Antiplatelet Therapy
por: Cui, Wen, et al.
Publicado: (2023)

The Role of Hs-CRP, D-Dimer and Fibrinogen in Differentiating Etiological Subtypes of Ischemic Stroke
por: Liu, Li-Bin, et al.
Publicado: (2015)

Association of Baseline Smoking Status with Long-Term Prognosis in Patients Who Underwent Percutaneous Coronary Intervention: Large Single-Center Data
por: Liu, Ru, et al.
Publicado: (2019)

Meta-Analysis of D-Dimer, hsCRP and Cytokines in COVID-19 Severe/Critical Patients in China
por: Zhang, Jie, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Association between inflammation, body mass index, and long-term outcomes in patients after percutaneous coronary intervention: A large cohort study
por: Zeng, Guyu, et al.
Publicado: (2023)

Correlation of clinical features with hs-CRP in TRD patients
por: Qiao, Juan, et al.
Publicado: (2019)

Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention
por: Zhao, Xueyan, et al.
Publicado: (2023)

Association of metabolic syndrome and level of hs-CRP, Lp(a), and serum ferritin in young Asian patients (≤45 years) with acute myocardial infarction
por: Ramesh, Gadepalli, et al.
Publicado: (2018)

Long-Term Clinical Outcomes for Non-ST Elevation Acute Coronary Syndrome Patients with High-Risk Angiographic Findings Undergoing Percutaneous Coronary Intervention
por: Jia, Sida, et al.
Publicado: (2020)

Prevalence of hs-CRP among Indians with hypertension
por: R, Vasanthii, et al.
Publicado: (2022)

hsCRP and ET-1 expressions in patients with no-reflow phenomenon after Percutaneous Coronary Intervention
por: Liu, Min, et al.
Publicado: (2017)

A risk score model of contrast-induced acute kidney injury in patients with emergency percutaneous coronary interventions
por: Yuan, Ying, et al.
Publicado: (2022)

Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention
por: Tan, Zheng, et al.
Publicado: (2019)

High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort
por: Wang, Peizhi, et al.
Publicado: (2022)

Correlation between hs-CRP and Asthma Control Indices
por: Sigari, Naseh, et al.
Publicado: (2013)

Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study
por: Yuan, Deshan, et al.
Publicado: (2021)

Long-Term Clinical Outcomes of Unprotected Left Main Percutaneous Coronary Intervention: A Large Single-Centre Experience
por: Gao, Lijian, et al.
Publicado: (2021)

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021)

Elevated HsCRP in Chronic Obstructive Pulmonary Disease: A Prospective Study of Long-Term Outcomes After Percutaneous Coronary Intervention
por: Zheng, Yitian, et al.
Publicado: (2022)

Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention
por: Guo, Tingting, et al.
Publicado: (2021)

The relationship among angiotensinogen genes polymorphisms and hs‐CRP and coronary artery disease
por: Zhu, Min, et al.
Publicado: (2019)

Relationship of HS CRP and Sacroiliac Joint Inflammation in Undifferentiated Spondyloarthritis
por: Liu, Te-Jung, et al.
Publicado: (2018)

Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients
por: Shang, Da, et al.
Publicado: (2017)

HsCRP in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Alavi, S A, et al.
Publicado: (2011)

Evaluation of Usefulness of hs-CRP and Ferritin Assays in Patients with Nasal Polyps
por: Partyka, Robert, et al.
Publicado: (2014)

The relationship between serum levels of hs-CRP and coronary lesion severity
por: RAZBAN, MOHAMMAD MEHDI, et al.
Publicado: (2016)

T94. HS-CRP TO EVALUATE CHRONIC INFLAMMATION AND CARDIOVASCULAR DISEASES IN SCHIZOPHRENIA
por: Nefzi, Rahma, et al.
Publicado: (2018)

IL-6 and hsCRP in Somatic Symptom Disorders and related disorders
por: van der Feltz-Cornelis, Christina M., et al.
Publicado: (2020)

Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
por: Chen, Runzhen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3apu4tdpkp8ti2mfcvc9mf502a